| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |